Literature DB >> 22446684

Structure-based inhibition of Norovirus RNA-dependent RNA polymerases.

Eloise Mastrangelo1, Margherita Pezzullo, Delia Tarantino, Roberto Petazzi, Francesca Germani, Dorothea Kramer, Ivonne Robel, Jacques Rohayem, Martino Bolognesi, Mario Milani.   

Abstract

Caliciviridae are RNA viruses with a single-stranded, positively oriented polyadenylated genome, responsible for a broad spectrum of diseases such as acute gastroenteritis in humans. Recently, analyses on the structures and functionalities of the RNA-dependent RNA polymerase (RdRp) from several Caliciviruses have been reported. The RdRp is predicted to play a key role in genome replication, as well as in synthesis and amplification of additional subgenomic RNA. Starting from the crystal structures of human Norovirus (hNV) RdRp, we performed an in silico docking search to identify synthetic compounds with predicted high affinity for the enzyme active site. The best-ranked candidates were tested in vitro on murine Norovirus (MNV) and hNV RdRps to assay their inhibition of RNA polymerization. The results of such combined computational and experimental screening approach led to the identification of two high-potency inhibitors: Suramin and NF023, both symmetric divalent molecules hosting two naphthalene-trisulfonic acid heads. We report here the crystal structure of MNV RdRp alone and in the presence of the two identified inhibitors. Both inhibitory molecules occupy the same RdRp site, between the fingers and thumb domains, with one inhibitor head close to residue 42 and to the protein active site. To further validate the structural results, we mutated Trp42 to Ala in MNV RdRp and the corresponding residue (i.e., Tyr41 to Ala) in hNV RdRp. Both NF023 and Suramin displayed reduced inhibitory potency versus the mutated hNV RdRp, thus hinting at a conserved inhibitor binding mode in the two polymerases.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446684     DOI: 10.1016/j.jmb.2012.03.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  37 in total

1.  Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin.

Authors:  Mary Ellenbecker; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

2.  Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.

Authors:  Auda A Eltahla; Kun Lee Lim; John-Sebastian Eden; Andrew G Kelly; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

Review 3.  Current tools for norovirus drug discovery.

Authors:  Sahani Weerasekara; Allan M Prior; Duy H Hua
Journal:  Expert Opin Drug Discov       Date:  2016-05-02       Impact factor: 6.098

4.  MicroRNA-223 Promotes Type I Interferon Production in Antiviral Innate Immunity by Targeting Forkhead Box Protein O3 (FOXO3).

Authors:  Luoquan Chen; Yinjing Song; Li He; Xiaopeng Wan; Lihua Lai; Feng Dai; Yang Liu; Qingqing Wang
Journal:  J Biol Chem       Date:  2016-05-13       Impact factor: 5.157

Review 5.  100 Years of Suramin.

Authors:  Natalie Wiedemar; Dennis A Hauser; Pascal Mäser
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

6.  Application of Molecular Dynamics Simulations to the Design of Nucleotide Inhibitors Binding to Norovirus Polymerase.

Authors:  Holly Freedman; Juthika Kundu; Egor Petrovitch Tchesnokov; John Lok Man Law; James A Nieman; Raymond F Schinazi; D Lorne Tyrrell; Matthias Gotte; Michael Houghton
Journal:  J Chem Inf Model       Date:  2020-12-01       Impact factor: 4.956

Review 7.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

Review 8.  Anti-norovirus therapeutics: a patent review (2010-2015).

Authors:  Anushka C Galasiti Kankanamalage; Pathum M Weerawarna; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Expert Opin Ther Pat       Date:  2016       Impact factor: 6.674

9.  Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential.

Authors:  Lianying Jiao; Songying Ouyang; Mifang Liang; Fengfeng Niu; Neil Shaw; Wei Wu; Wei Ding; Cong Jin; Yao Peng; Yanping Zhu; Fushun Zhang; Tao Wang; Chuan Li; Xiaobing Zuo; Chi-Hao Luan; Dexin Li; Zhi-Jie Liu
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

Review 10.  Antiviral targets of human noroviruses.

Authors:  Bv Venkataram Prasad; Sreejesh Shanker; Zana Muhaxhiri; Lisheng Deng; Jae-Mun Choi; Mary K Estes; Yongcheng Song; Timothy Palzkill; Robert L Atmar
Journal:  Curr Opin Virol       Date:  2016-06-17       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.